Hipertensión y riesgo vascular

• 

  Año 2025, Vol. 42, Número 2. Texto Completo Ejemplar

  • Editorial

    • Hypertension and uric acid, uric acid and hypertension: Is hyperuricaemia a new vascular risk factor to take into account?

      Mència Benítez Camps

      • Texto completo

      págs. 63-64

      

    • Refractory arterial hypertension. What can we offer these patients?

      Julián Segura de la Morena, Pedro Armario García

      • Texto completo

      págs. 65-66

      

  • Originales

    • Real-world efficacy and safety of baroreceptor activation therapy in a series of patients with refractory arterial hypertension

      A. Bustos Merlo, D. Rico López, Fernando Jaén Águila, Cristina López Espada, M.I. Rodríguez Macías, Juan Diego Mediavilla García

      • Resumen
      • Texto completo

      págs. 67-71

      

    • Association of different domains of sedentary behavior and cardiovascular risk factors in adolescents: Cross-sectional study

      E.P. Antunes, W.R. Tebar, G.G. Cucato, C.C.M. Silva, I. Leoci, A.B. dos Santos, G. Ferrari, Diego G. D Christofaro

      • Resumen
      • Texto completo

      págs. 72-78

      

    • Physicians’ perception of guideline recommendations for the treatment of resistant hypertension by renal denervation: Resistant Hypertension Working Group, Argentine Hypertension Society

      N.F. Renna, Laura Brandani, R. Parodi, Carol Kotliar, E. Ylarri, Gustavo Lavenia, M. Marin, M. Ruise, R. Sanchez, D. Cianfagna, G. Botvinik, P. Rumi, V. Ferretti, P. Rodríguez

      • Resumen
      • Texto completo

      págs. 79-84

      

    • The complex interplay: How lifestyle and psychosocial factors contribute to hypertension in myocardial infarction patients—An integrated model

      H. Roohafza, M. Mansourian, F. Zarimeidani, R. Rahmati, N. Shakibaei, H. Marateb, F. Noohi, A. Salari, M. Sadeghi Shabestari

      • Resumen
      • Texto completo

      págs. 85-93

      

    • Comparison of the effectiveness of aliskiren and ramipril for the management of hypertension: A systematic review and meta-analysis

      T. Alam, M. Asif Ansari

      • Resumen
      • Texto completo

      págs. 94-101

      

  • Artículo especial

    • Position statement on the use of amlodipine during pregnancy. Working Group on Hypertension in Women, Argentine Society of Hypertension

      A.M. Ghelfi, G. Miranda, L.S. Voto, Mildred A. Del Sueldo, Judith M. Zilberman, R. Mondino, M.P. Pérez, P.G. Irusta, L. Meccia, E. Martínez Marissi, M. Laura Baiche, F. Waisman, M. Baroni, M.V. Ferretti, J.P. Morán, Andrea Corrales Barboza, Alejandro M. Delucchi, Pablo D. Rodríguez, N.F. Renna

      • Resumen
      • Texto completo

      págs. 102-107

      

    • Positioning for the use of multivessel clinical ultrasound in vascular risk evaluation: VASUS+ protocol. 2024 recommendations of the Vascular Risk Group, clinical ultrasound of the Spanish Society of Internal Medicine and Spanish Society of Hypertension and Vascular Risk

      E. Moya Mateo, M. R. García Alonso, C. Sánchez Sánchez, Yale Tung Chen, Enrique Rodilla Sala, L. Beltrán Romero, J. A. García Donaire, M.V. Bonilla Hernández, Nuria Muñoz Rivas, Luis Castilla Guerra

      • Resumen
      • Texto completo

      págs. 108-115

      

  • Revisión

    • Cutting-edge lipid-lowering pharmacological therapies: Improving lipid control beyond statins

      M. Capuozzo, A. Ottaiano, C. Cinque, S. Farace, F. Ferrara

      • Resumen
      • Texto completo

      págs. 116-127